SPDR S&P Biotech ETF $XBI Stock Holdings Boosted by Sowell Financial Services LLC

Sowell Financial Services LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 103.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,116 shares of the exchange traded fund’s stock after acquiring an additional 8,192 shares during the quarter. Sowell Financial Services LLC’s holdings in SPDR S&P Biotech ETF were worth $2,541,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Bank of America Corp DE increased its holdings in SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Main Street Research LLC increased its stake in shares of SPDR S&P Biotech ETF by 57.4% during the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after buying an additional 206,953 shares during the period. Strs Ohio raised its holdings in SPDR S&P Biotech ETF by 4.9% in the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock valued at $52,433,000 after acquiring an additional 19,300 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in SPDR S&P Biotech ETF by 145.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after acquiring an additional 186,314 shares in the last quarter. Finally, Annex Advisory Services LLC raised its holdings in SPDR S&P Biotech ETF by 4.6% in the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after acquiring an additional 11,723 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.7%

Shares of SPDR S&P Biotech ETF stock opened at $151.64 on Friday. SPDR S&P Biotech ETF has a 52-week low of $106.30 and a 52-week high of $169.89. The company has a 50 day moving average of $157.56 and a 200 day moving average of $147.71. The company has a market capitalization of $10.31 billion, a P/E ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.